Literature DB >> 19111492

Modified temporal approach for a rostro-temporal basal meningioma in a cat.

Franck Forterre1, André Jaggy, Helene Rohrbach, Marc Dickomeit, Martin Konar.   

Abstract

An 11-year-old neutered female domestic shorthair indoor cat was presented to our hospital for treatment of a left-sided rostro-temporal basal meningioma. Focal seizures in the facial muscles had been observed sporadically for 1 year. Two weeks prior to presentation the cat had developed generalised seizures and was treated with symptomatic anticonvulsive treatment. Focal facial seizures, especially on the right side, persisted after medical therapy. From the computed tomography scan, a basal meningioma was suspected by the treating veterinarian. A left-sided suprazygomatical temporobasal approach to the zygomatic arch was chosen because it causes less soft tissue damage. After craniotomy, durotomy and gentle dorsal retraction of the left piriform lobe, the meningioma was removed. Postoperative magnetic resonance imaging confirmed complete excision of the tumour. One day after surgery the cat was alert and a left-sided facial nerve palsy was noticed. Otherwise the neurological examination was normal. Anticonvulsive and eye moistening therapy was continued for 3 months. Six months after surgery the cat was clinically normal without any recurrence of seizures.

Entities:  

Mesh:

Year:  2008        PMID: 19111492     DOI: 10.1016/j.jfms.2008.11.002

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  2 in total

1.  Formation of a meningoencephalocele after removal of a frontal lobe meningioma by transfrontal craniotomy in a cat.

Authors:  Christian Günther; Katrin M Beckmann; Frank Steffen
Journal:  JFMS Open Rep       Date:  2020-09-15

2.  Partial cortico-hippocampectomy in cats, as therapy for refractory temporal epilepsy: A descriptive cadaveric study.

Authors:  Jessica Zilli; Monika Kressin; Anne Schänzer; Marian Kampschulte; Martin J Schmidt
Journal:  PLoS One       Date:  2021-01-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.